| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Age-related differences in risks and outcomes of 30-day readmission in adults with sickle cell disease
|
Chen, Ming
|
|
|
102 |
Suppl 1 |
p. 2329-2342
|
artikel
|
| 2 |
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: prognostic indicators and the role of JAK2V617F measurable-residual disease monitoring by droplet-digital polymerase chain reaction
|
Li, Vivian W.K.
|
|
|
102 |
Suppl 1 |
p. 2517-2527
|
artikel
|
| 3 |
Allogeneic hematopoietic stem cell transplantation remains a feasible approach for elderly with acute myeloid leukemia: a 10-year experience
|
Duda, Katarzyna
|
|
|
102 |
Suppl 1 |
p. 1907-1914
|
artikel
|
| 4 |
Allogeneic stem cell transplantation in patients with a prior history of prostate cancer
|
Palmieri, Raffaele
|
|
|
102 |
Suppl 1 |
p. 407-412
|
artikel
|
| 5 |
Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensity score analysis of a nationwide database
|
Itonaga, Hidehiro
|
|
|
102 |
Suppl 1 |
p. 1215-1227
|
artikel
|
| 6 |
All-trans retinoic acid added to treatment of primary immune thrombocytopenia: a systematic review and meta-analysis
|
Yang, Jinjun
|
|
|
102 |
Suppl 1 |
p. 1695-1704
|
artikel
|
| 7 |
Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysis
|
Kuron, David
|
|
|
102 |
Suppl 1 |
p. 755-760
|
artikel
|
| 8 |
Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination
|
Jacobs, Jeremy W.
|
|
|
102 |
Suppl 1 |
p. 955-959
|
artikel
|
| 9 |
An analysis of sintilimab combined with ruxolitinib as compassionate therapy for 12 adults with EBV-associated hemophagocytic lymphohistiocytosis
|
Xu, Ying
|
|
|
102 |
Suppl 1 |
p. 3325-3333
|
artikel
|
| 10 |
A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis
|
Wang, Shixuan
|
|
|
102 |
Suppl 1 |
p. 3251-3259
|
artikel
|
| 11 |
Antithrombotic secondary prophylaxis with low dose of apixaban or rivaroxaban in the onco-hematologic patients: comparison with non-neoplastic patients
|
Chistolini, A.
|
|
|
102 |
Suppl 1 |
p. 2599-2605
|
artikel
|
| 12 |
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
|
Xu, Lengnan
|
|
|
102 |
Suppl 1 |
p. 2251-2256
|
artikel
|
| 13 |
A pilot study of cord blood-derived natural killer cells as maintenance therapy after autologous hematopoietic stem cell transplantation
|
Wu, Yuling
|
|
|
102 |
Suppl 1 |
p. 3229-3237
|
artikel
|
| 14 |
A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia
|
Jongkraijakra, Siddhibhong
|
|
|
102 |
Suppl 1 |
p. 1333-1340
|
artikel
|
| 15 |
A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy
|
Berdel, Andrew F.
|
|
|
102 |
Suppl 1 |
p. 63-72
|
artikel
|
| 16 |
Are accessory spleen screening and resection in refractory immune cytopenia an effective strategy or a waste of resources?
|
Rodríguez-Rodríguez, Sergio
|
|
|
102 |
Suppl 1 |
p. 2309-2315
|
artikel
|
| 17 |
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin’s lymphoma
|
Gaudio, Francesco
|
|
|
102 |
Suppl 1 |
p. 385-392
|
artikel
|
| 18 |
Association between ABO blood group/genotype and COVID-19 in a Japanese population
|
Kusumoto, Tatsuya
|
|
|
102 |
Suppl 1 |
p. 3239-3249
|
artikel
|
| 19 |
Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region
|
Sticchi Damiani, Alessia
|
|
|
102 |
Suppl 1 |
p. 2923-2931
|
artikel
|
| 20 |
Association between anemia and depression: results from NHANES 2005–2018 and mendelian randomization analyses
|
Wang, Yashan
|
|
|
102 |
Suppl 1 |
p. 2651-2658
|
artikel
|
| 21 |
Association between N-acetylcysteine treatment and in-hospital mortality in adult patients with acquired thrombotic thrombocytopenic purpura: a cohort study
|
Li, Jing
|
|
|
102 |
Suppl 1 |
p. 2257-2265
|
artikel
|
| 22 |
Association of inflammation and abnormal lipid metabolism with risk of thrombosis and thrombosis progression in patients with polycythemia vera: a retrospective study
|
Lai, Hurong
|
|
|
102 |
Suppl 1 |
p. 3413-3426
|
artikel
|
| 23 |
Autoimmune Hemolytic Anemia in the Pediatric Age Group: The Egyptian Experience
|
Abdel-Salam, Amina
|
|
|
102 |
Suppl 1 |
p. 1687-1694
|
artikel
|
| 24 |
Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study
|
Wu, Meng
|
|
|
102 |
Suppl 1 |
p. 3185-3193
|
artikel
|
| 25 |
Autologous stem cell transplantation in multiple myeloma patients with renal impairment
|
Zhai, Yingying
|
|
|
102 |
Suppl 1 |
p. 621-628
|
artikel
|
| 26 |
Bleeding risk assessment in immune thrombocytopenia
|
Mishra, Kundan
|
|
|
102 |
Suppl 1 |
p. 3007-3014
|
artikel
|
| 27 |
Brazilian experience with caplacizumab in acquired thrombotic thrombocytopenic purpura: outcomes of the expanded access program
|
de Oliveira Boechat, Tiago
|
|
|
102 |
Suppl 1 |
p. 1581-1588
|
artikel
|
| 28 |
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)
|
Kim, Mihee
|
|
|
102 |
Suppl 1 |
p. 2233-2240
|
artikel
|
| 29 |
CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease
|
Shen, Yao-jia
|
|
|
102 |
Suppl 1 |
p. 1731-1738
|
artikel
|
| 30 |
Can we lower the platelet threshold of ≥ 50 × 109/L for performing a lumbar puncture safely in patients with hematological malignancies?
|
Jordan, Aryanna
|
|
|
102 |
Suppl 1 |
p. 663-668
|
artikel
|
| 31 |
Central nervous system involvement at initial diagnosis of extranodal NK/T-cell lymphoma: a retrospective study of a consecutive 12-year case series
|
Wu, Wanchun
|
|
|
102 |
Suppl 1 |
p. 829-839
|
artikel
|
| 32 |
Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Center for Hematologic Disease
|
He, Qing
|
|
|
102 |
Suppl 1 |
p. 2857-2864
|
artikel
|
| 33 |
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis
|
Garcia Borrega, Jorge
|
|
|
102 |
Suppl 1 |
p. 191-197
|
artikel
|
| 34 |
Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments
|
Zhang, Yanjie
|
|
|
102 |
Suppl 1 |
p. 801-809
|
artikel
|
| 35 |
Chronic active Epstein-Barr virus infection involving gastrointestinal tract with hemophagocytic lymphohistiocytosis
|
Shen, Kai
|
|
|
102 |
Suppl 1 |
p. 45-53
|
artikel
|
| 36 |
Clinical and prognostic role of sarcopenia based on masticatory muscle index on MR images in patients with extranodal natural killer/T cell lymphoma, nasal type
|
Xu, Tianzi
|
|
|
102 |
Suppl 1 |
p. 3521-3532
|
artikel
|
| 37 |
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group
|
Soboń, Anita
|
|
|
102 |
Suppl 1 |
p. 2119-2126
|
artikel
|
| 38 |
Clinical features and current treatment status of essential thrombocythemia in older adults: a multicenter real-world study in China
|
Fu, Rongfeng
|
|
|
102 |
Suppl 1 |
p. 2097-2107
|
artikel
|
| 39 |
Clinical features and prognostic risk prediction of adult hemophagocytic lymphohistiocytosis: a 9-year retrospective study
|
Qiu, Qunxiang
|
|
|
102 |
Suppl 1 |
p. 2671-2682
|
artikel
|
| 40 |
Clinical significance of high-dose chemotherapy with autologous stem cell transplantation in the era of novel agents in patients older than 65 years with multiple myeloma
|
Sato, Shuku
|
|
|
102 |
Suppl 1 |
p. 1185-1191
|
artikel
|
| 41 |
Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study
|
Li, Junnan
|
|
|
102 |
Suppl 1 |
p. 2153-2163
|
artikel
|
| 42 |
Comparative efficacy and safety of restrictive versus liberal transfusion thresholds in anemic preterm infants: a meta-analysis of 12 randomized controlled trials
|
Fu, Xiaoling
|
|
|
102 |
Suppl 1 |
p. 283-297
|
artikel
|
| 43 |
Comparing the efficacy of salvage regimens for relapsed/refractory B-cell acute lymphoblastic leukaemia: a systematic review and network meta-analysis
|
Cao, Han-Yu
|
|
|
102 |
Suppl 1 |
p. 155-165
|
artikel
|
| 44 |
Comparison of haploidentical–allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study
|
Wu, Li-qiang
|
|
|
102 |
Suppl 1 |
p. 2015-2023
|
artikel
|
| 45 |
Comparison of multiple treatments in the management of transplant-related thrombotic microangiopathy: a network meta-analysis
|
Yang, Jingyi
|
|
|
102 |
Suppl 1 |
p. 31-39
|
artikel
|
| 46 |
Comparison of outcomes for patients with acute myeloid leukemia undergoing haploidentical stem cell transplantation in first and second complete remission
|
Yu, Wen-Jing
|
|
|
102 |
Suppl 1 |
p. 2241-2250
|
artikel
|
| 47 |
Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms
|
Katamesh, Bahga
|
|
|
102 |
Suppl 1 |
p. 211-212
|
artikel
|
| 48 |
Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation
|
Martino, Massimo
|
|
|
102 |
Suppl 1 |
p. 2297-2298
|
artikel
|
| 49 |
Correction to: Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders
|
Migaud, Pascal
|
|
|
102 |
Suppl 1 |
p. 1971
|
artikel
|
| 50 |
Correction to: Real‑world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response
|
Ferreira, Amanda Pifano Soares
|
|
|
102 |
Suppl 1 |
p. 1969
|
artikel
|
| 51 |
COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma
|
Nachar, Victoria R.
|
|
|
102 |
Suppl 1 |
p. 2635-2637
|
artikel
|
| 52 |
Cytogenetic evolution predicts a poor prognosis in acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
|
Li, Ruiqi
|
|
|
102 |
Suppl 1 |
p. 89-97
|
artikel
|
| 53 |
Daratumumab—a novel treatment strategy in relapsed/refractory acute leukemia
|
Borah, Pronamee
|
|
|
102 |
Suppl 1 |
p. 3291-3293
|
artikel
|
| 54 |
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA
|
Suzuki, Kenshi
|
|
|
102 |
Suppl 1 |
p. 863-876
|
artikel
|
| 55 |
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
|
Stork, Martin
|
|
|
102 |
Suppl 1 |
p. 1501-1511
|
artikel
|
| 56 |
Delay in treatment of adult hemophagocytic lymphohistiocytosis is associated with worse in-hospital outcomes
|
Abdelhay, Ali
|
|
|
102 |
Suppl 1 |
p. 2989-2996
|
artikel
|
| 57 |
Depression and anxiety among hemophilia patients enrolled in clinical trials: a multi-center cohort study
|
Peng, Zhen
|
|
|
102 |
Suppl 1 |
p. 1927-1937
|
artikel
|
| 58 |
Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China
|
Li, Xiaosheng
|
|
|
102 |
Suppl 1 |
p. 3465-3475
|
artikel
|
| 59 |
Differentiation syndrome and coagulation disorder — comparison between treatment with oral and intravenous arsenics in pediatric acute promyelocytic leukemia
|
Luo, Jie-Si
|
|
|
102 |
Suppl 1 |
p. 1713-1721
|
artikel
|
| 60 |
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study
|
Niederwieser, Dietger
|
|
|
102 |
Suppl 1 |
p. 547-561
|
artikel
|
| 61 |
Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia
|
Kimura, Hiroyuki
|
|
|
102 |
Suppl 1 |
p. 3103-3113
|
artikel
|
| 62 |
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis
|
Cioccio, Joseph
|
|
|
102 |
Suppl 1 |
p. 613-620
|
artikel
|
| 63 |
Early cerebrospinal fluid infiltration in TP53-mutated blastic plasmacytoid dendritic cell neoplasm
|
Michaelis, Simon
|
|
|
102 |
Suppl 1 |
p. 491-493
|
artikel
|
| 64 |
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation
|
Martino, Massimo
|
|
|
102 |
Suppl 1 |
p. 1915-1925
|
artikel
|
| 65 |
Effectiveness of single-dose 6 mg pegfilgrastim in mobilizing peripheral blood stem cells in allogeneic hematopoietic cell transplantation donors
|
Cao, Junjie
|
|
|
102 |
Suppl 1 |
p. 3567-3573
|
artikel
|
| 66 |
Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan
|
Iemura, Tomoki
|
|
|
102 |
Suppl 1 |
p. 2909-2922
|
artikel
|
| 67 |
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics
|
Yamasaki, Satoshi
|
|
|
102 |
Suppl 1 |
p. 1549-1559
|
artikel
|
| 68 |
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials
|
Luciano, Luigia
|
|
|
102 |
Suppl 1 |
p. 1375-1382
|
artikel
|
| 69 |
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group
|
Koschmieder, Steffen
|
|
|
102 |
Suppl 1 |
p. 349-358
|
artikel
|
| 70 |
Efficacy and safety-related factors of BTK inhibitors as a bridge to CAR-T therapy in R/R FL
|
Ye, Xiupeng
|
|
|
102 |
Suppl 1 |
p. 1789-1799
|
artikel
|
| 71 |
Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasms
|
Zheng, Xinhui
|
|
|
102 |
Suppl 1 |
p. 3603-3611
|
artikel
|
| 72 |
Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study Group
|
Thanhakun, Ronakrit
|
|
|
102 |
Suppl 1 |
p. 3533-3541
|
artikel
|
| 73 |
Epidemiology and early mortality patterns of acute promyelocytic leukemia in the United States
|
Sharma, Aditi
|
|
|
102 |
Suppl 1 |
p. 1053-1062
|
artikel
|
| 74 |
Epstein–Barr virus reactivation correlates with worse outcomes for patients exposed to hepatitis B virus after haploidentical hematopoietic stem cell transplantation
|
Hu, Jiajia
|
|
|
102 |
Suppl 1 |
p. 3593-3601
|
artikel
|
| 75 |
Estimated glomerular filtration rate in Brazilian adults with sickle cell disease: results from the REDS-III multicenter cohort study
|
Belisário, André Rolim
|
|
|
102 |
Suppl 1 |
p. 1019-1027
|
artikel
|
| 76 |
Estimating prognostic relevant cutoff values for a multiplex PCR detecting BCR::ABL1 in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy in resource-limited settings
|
Hailu, Saifu
|
|
|
102 |
Suppl 1 |
p. 1723-1729
|
artikel
|
| 77 |
Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring
|
Coe-Eisenberg, Taylor D.
|
|
|
102 |
Suppl 1 |
p. 3133-3141
|
artikel
|
| 78 |
Evaluation of different pharmacokinetically guided IV busulfan exposure ranges on adult patient outcomes after hematopoietic stem cell transplantation
|
Mori, Shahram
|
|
|
102 |
Suppl 1 |
p. 181-190
|
artikel
|
| 79 |
Excess deaths among adults with sickle cell disease in 2020 compared to prior years
|
Curtis, Susanna
|
|
|
102 |
Suppl 1 |
p. 41-44
|
artikel
|
| 80 |
Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients
|
van der Zouwen, Boris
|
|
|
102 |
Suppl 1 |
p. 1203-1213
|
artikel
|
| 81 |
Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation
|
Kamijo, Kimimori
|
|
|
102 |
Suppl 1 |
p. 651-661
|
artikel
|
| 82 |
Generic ibrutinib a potential cost-effective strategy for the first-line treatment of chronic lymphocytic leukaemia
|
Hegde, Naveen C
|
|
|
102 |
Suppl 1 |
p. 3125-3132
|
artikel
|
| 83 |
Genomic and computational analysis of four novel variants of MPL gene in Congenital Amegakaryocytic Thrombocytopenia
|
Shah, Anjali
|
|
|
102 |
Suppl 1 |
p. 2683-2693
|
artikel
|
| 84 |
Gut microbiome alterations in patients with COVID-19-related coagulopathy
|
Chen, Youli
|
|
|
102 |
Suppl 1 |
p. 1589-1598
|
artikel
|
| 85 |
Heme oxygenase 1 in erythropoiesis: an important regulator beyond catalyzing heme catabolism
|
Liu, Rui
|
|
|
102 |
Suppl 1 |
p. 1323-1332
|
artikel
|
| 86 |
Hemophagocytic lymphohistiocytosis in inflammatory bowel disease: a nationwide analysis
|
Mahmoud, Amir A.
|
|
|
102 |
Suppl 1 |
p. 1705-1711
|
artikel
|
| 87 |
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy
|
Visentini, Marcella
|
|
|
102 |
Suppl 1 |
p. 3457-3463
|
artikel
|
| 88 |
High TOX expression on CD8+ T cells in pure red cell aplasia
|
Niu, Haiyue
|
|
|
102 |
Suppl 1 |
p. 1247-1255
|
artikel
|
| 89 |
Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis
|
Doucette, Kimberley
|
|
|
102 |
Suppl 1 |
p. 1443-1458
|
artikel
|
| 90 |
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study
|
Weng, Guangyang
|
|
|
102 |
Suppl 1 |
p. 3369-3381
|
artikel
|
| 91 |
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network)
|
Cencini, Emanuele
|
|
|
102 |
Suppl 1 |
p. 841-849
|
artikel
|
| 92 |
IL-10 plus the EASIX score predict bleeding events after anti-CD19 CAR T-cell therapy
|
Wang, Xindi
|
|
|
102 |
Suppl 1 |
p. 3575-3585
|
artikel
|
| 93 |
Impact of extramedullary disease in AML patients undergoing sequential RIC for HLA-matched transplantation: occurrence, risk factors, relapse patterns, and outcome
|
Fraccaroli, Alessia
|
|
|
102 |
Suppl 1 |
p. 2213-2223
|
artikel
|
| 94 |
Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients
|
Perrone, Salvatore
|
|
|
102 |
Suppl 1 |
p. 769-775
|
artikel
|
| 95 |
Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP
|
Kim, Moonho
|
|
|
102 |
Suppl 1 |
p. 3167-3175
|
artikel
|
| 96 |
Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation
|
Xu, Jingyu
|
|
|
102 |
Suppl 1 |
p. 3195-3204
|
artikel
|
| 97 |
Impacts of early therapy response, interval to therapy interruption, and cumulative therapy interruption duration on outcome of ibrutinib therapy in relapsed/refractory chronic lymphocytic leukemia
|
Yang, Shenmiao
|
|
|
102 |
Suppl 1 |
p. 2181-2188
|
artikel
|
| 98 |
Improved benefit of continuing luspatercept therapy: sub-analysis of patients with lower-risk MDS in the MEDALIST study
|
Germing, Ulrich
|
|
|
102 |
Suppl 1 |
p. 311-321
|
artikel
|
| 99 |
Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary
|
Husi, Kata
|
|
|
102 |
Suppl 1 |
p. 2555-2563
|
artikel
|
| 100 |
Infectious complications following CAR-t cell therapy for B cell non-Hodgkin lymphoma: a single-center experience and review of the literature
|
Mercadal, Santiago
|
|
|
102 |
Suppl 1 |
p. 1837-1843
|
artikel
|
| 101 |
Insulin-like growth factor 1 receptor inhibits the proliferation of acute myeloid leukaemia cells via NK cell activation
|
Wang, ShuQing
|
|
|
102 |
Suppl 1 |
p. 2353-2364
|
artikel
|
| 102 |
Integrated single-cell transcriptome analysis of CD34 + enriched leukemic stem cells revealed intra- and inter-patient transcriptional heterogeneity in pediatric acute myeloid leukemia
|
Thakral, Deepshi
|
|
|
102 |
Suppl 1 |
p. 73-87
|
artikel
|
| 103 |
Lack of surgical resection is associated with increased early mortality in hematological patients complicated with rhino-orbital-cerebral mucormycosis
|
Chen, Xinyue
|
|
|
102 |
Suppl 1 |
p. 2933-2942
|
artikel
|
| 104 |
Long noncoding RNA FAM157C contributes to clonal proliferation in paroxysmal nocturnal hemoglobinuria
|
Wang, Honglei
|
|
|
102 |
Suppl 1 |
p. 299-309
|
artikel
|
| 105 |
Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry
|
Burns, Ethan A.
|
|
|
102 |
Suppl 1 |
p. 1111-1120
|
artikel
|
| 106 |
Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry
|
Burns, Ethan A.
|
|
|
102 |
Suppl 1 |
p. 2753-2763
|
artikel
|
| 107 |
Macrophage depletion using clodronate liposomes reveals latent dysfunction of the hematopoietic microenvironment associated with persistently imbalanced M1/M2 macrophage polarization in a mouse model of hemophagocytic lymphohistiocytosis
|
Koike, Takashi
|
|
|
102 |
Suppl 1 |
p. 3311-3323
|
artikel
|
| 108 |
Management and outcome of 500 multiple myeloma patients treated for first relapse outside clinical studies
|
Avivi, Irit
|
|
|
102 |
Suppl 1 |
p. 3075-3081
|
artikel
|
| 109 |
Mass cytometry analysis identifies T cell immune signature of aplastic anemia and predicts the response to cyclosporine
|
Zhang, Lele
|
|
|
102 |
Suppl 1 |
p. 529-539
|
artikel
|
| 110 |
Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES study
|
Iglesias-Vázquez, Lucía
|
|
|
102 |
Suppl 1 |
p. 741-748
|
artikel
|
| 111 |
Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia
|
Zhao, Jin
|
|
|
102 |
Suppl 1 |
p. 2565-2587
|
artikel
|
| 112 |
Molecular insights into hereditary elliptocytosis and pyropoikilocytosis: NGS uncovers multiple potential candidate genes
|
Shome, Durjoy K.
|
|
|
102 |
Suppl 1 |
p. 2343-2351
|
artikel
|
| 113 |
Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blasts
|
Kasprzak, A.
|
|
|
102 |
Suppl 1 |
p. 99-106
|
artikel
|
| 114 |
Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers
|
Frank, Benedikt
|
|
|
102 |
Suppl 1 |
p. 603-611
|
artikel
|
| 115 |
Mutations in the plasma cell clone identify mechanism of polyneuropathy in a case of POEMS syndrome associated with Castleman disease and multiple myeloma
|
Brioli, Annamaria
|
|
|
102 |
Suppl 1 |
p. 239-242
|
artikel
|
| 116 |
MYC-targeted genes predict distant recurrence in patients with ocular adnexal extranodal marginal zone lymphoma
|
Zhu, Tianyu
|
|
|
102 |
Suppl 1 |
p. 2413-2423
|
artikel
|
| 117 |
Myeloid sarcoma: more and less than a distinct entity
|
Loscocco, Giuseppe G.
|
|
|
102 |
Suppl 1 |
p. 1973-1984
|
artikel
|
| 118 |
Ofatumumab regimens in chronic lymphocytic leukemia: a meta-analysis
|
Ashoub, Muhammad Hossein
|
|
|
102 |
Suppl 1 |
p. 1301-1306
|
artikel
|
| 119 |
One disease, two faces: clonally-related AML and MPDCP with skin involvement
|
Martino, Giovanni
|
|
|
102 |
Suppl 1 |
p. 2969-2971
|
artikel
|
| 120 |
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study
|
Li, Jia-Ying
|
|
|
102 |
Suppl 1 |
p. 2459-2469
|
artikel
|
| 121 |
Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma
|
Johansson, Patricia
|
|
|
102 |
Suppl 1 |
p. 3445-3455
|
artikel
|
| 122 |
Outcomes of polatuzumab vedotin-containing regimens in real-world setting of relapsed and or refractory diffuse large B-cell lymphoma patients: a matched-control analysis from the Thai Lymphoma Study Group (TLSG)
|
Rattanathammethee, Thanawat
|
|
|
102 |
Suppl 1 |
p. 1887-1895
|
artikel
|
| 123 |
Pain: a neglected symptom in hemophilia
|
Kurçaloğlu, Mustafa
|
|
|
102 |
Suppl 1 |
p. 947-953
|
artikel
|
| 124 |
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort
|
Cattaneo, Daniele
|
|
|
102 |
Suppl 1 |
p. 1409-1420
|
artikel
|
| 125 |
Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia
|
Viprakasit, Vip
|
|
|
102 |
Suppl 1 |
p. 2039-2049
|
artikel
|
| 126 |
Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era
|
Qi, Feiyang
|
|
|
102 |
Suppl 1 |
p. 2707-2716
|
artikel
|
| 127 |
PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphoma
|
Ping, Liqin
|
|
|
102 |
Suppl 1 |
p. 2189-2198
|
artikel
|
| 128 |
Pediatric chemotherapy versus allo-HSCT for adolescent and adult Philadelphia chromosome-negative ALL in first complete remission: a meta-analysis
|
Pan, Zengkai
|
|
|
102 |
Suppl 1 |
p. 1131-1140
|
artikel
|
| 129 |
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain
|
Ortuzar, Ariana
|
|
|
102 |
Suppl 1 |
p. 447-456
|
artikel
|
| 130 |
PH negative acute lymphoblastic leukemia in adolescents and young adults treated according a MRD adapted BFM ALL IC 2009 protocol: Argentine real-world data on 171 patients
|
Ferrari, Luciana C
|
|
|
102 |
Suppl 1 |
p. 1087-1097
|
artikel
|
| 131 |
Platelet is an unfavorable prognostic biomarker and associated with leukemia stem cells and immunomodulatory factors in acute myeloid leukemia
|
Zhang, Qing
|
|
|
102 |
Suppl 1 |
p. 2365-2373
|
artikel
|
| 132 |
Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey
|
Dal, Mehmet Sinan
|
|
|
102 |
Suppl 1 |
p. 133-140
|
artikel
|
| 133 |
Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy
|
Araie, Hiroaki
|
|
|
102 |
Suppl 1 |
p. 2879-2893
|
artikel
|
| 134 |
Positron emission tomography to detect bone marrow involvement for patients with follicular lymphoma: a systematic review and meta-analysis
|
Zheng, Yaxin
|
|
|
102 |
Suppl 1 |
p. 2403-2412
|
artikel
|
| 135 |
Predictive scoring system for distinguishing Stenotrophomonas maltophilia bacteremia from Pseudomonas aeruginosa bacteremia in patients with hematological malignancies
|
Sakoh, Takashi
|
|
|
102 |
Suppl 1 |
p. 1239-1246
|
artikel
|
| 136 |
Predictors of health-related quality of life of the patients treated for MM: the first study in the Palestinian healthcare system
|
Shawahna, Ramzi
|
|
|
102 |
Suppl 1 |
p. 3543-3554
|
artikel
|
| 137 |
Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study
|
Infante, Joana
|
|
|
102 |
Suppl 1 |
p. 3031-3037
|
artikel
|
| 138 |
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML)
|
Pohlmann, Alexander
|
|
|
102 |
Suppl 1 |
p. 2543-2553
|
artikel
|
| 139 |
Prevalence and prognostic significance of IKZF1 deletion in paediatric acute lymphoblastic leukemia: A systematic review and meta-analysis
|
Srinivasan, Shyam
|
|
|
102 |
Suppl 1 |
p. 2165-2179
|
artikel
|
| 140 |
Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course
|
Delehaye, Fanny
|
|
|
102 |
Suppl 1 |
p. 563-570
|
artikel
|
| 141 |
Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?
|
Wu, Pei-Hua
|
|
|
102 |
Suppl 1 |
p. 907-916
|
artikel
|
| 142 |
Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma
|
Ebid, Osama Abd El Hameed
|
|
|
102 |
Suppl 1 |
p. 3477-3488
|
artikel
|
| 143 |
Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study
|
Juliette, Pénichoux
|
|
|
102 |
Suppl 1 |
p. 1811-1823
|
artikel
|
| 144 |
Prognostic significance of absolute monocyte count and lymphocyte to monocyte ratio in mucosa-associated lymphoid tissue (MALT) lymphoma
|
Shang, Chun-Yu
|
|
|
102 |
Suppl 1 |
p. 359-367
|
artikel
|
| 145 |
Prognostic value of metabolic tumor volume of extranodal involvement in diffuse large B cell lymphoma
|
Oiwa, Kana
|
|
|
102 |
Suppl 1 |
p. 1141-1148
|
artikel
|
| 146 |
Prognostic value of multiparametric cardiac magnetic resonance in sickle cell patients
|
Meloni, Antonella
|
|
|
102 |
Suppl 1 |
p. 261-270
|
artikel
|
| 147 |
Prognostic value of soluble programmed cell death ligand-1 (sPD-L1) in lymphoma: a systematic review and meta-analysis
|
Ding, Yangyang
|
|
|
102 |
Suppl 1 |
p. 2425-2434
|
artikel
|
| 148 |
Pseudothrombocytopenia, beyond a laboratory phenomenon: study of 192 cases
|
Pujol-Moix, Núria
|
|
|
102 |
Suppl 1 |
p. 1363-1374
|
artikel
|
| 149 |
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial
|
Koschmieder, Steffen
|
|
|
102 |
Suppl 1 |
p. 3383-3399
|
artikel
|
| 150 |
Real-world clinical outcomes in patients with multiple myeloma treated with isatuximab after daratumumab treatment
|
Kikuchi, Taku
|
|
|
102 |
Suppl 1 |
p. 1477-1483
|
artikel
|
| 151 |
Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies
|
Kikuchi, Taku
|
|
|
102 |
Suppl 1 |
p. 3489-3497
|
artikel
|
| 152 |
Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study
|
Macro, M.
|
|
|
102 |
Suppl 1 |
p. 2137-2151
|
artikel
|
| 153 |
Real-world Imatinib Mesylate Treatment in Patients with Chronic Myeloid Leukemia: The Importance of Molecular Monitoring and the Early Molecular Response
|
Ferreira, Amanda Pifano Soares
|
|
|
102 |
Suppl 1 |
p. 1761-1771
|
artikel
|
| 154 |
Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen
|
Reed, Daniel R.
|
|
|
102 |
Suppl 1 |
p. 897-906
|
artikel
|
| 155 |
Real world outcomes of lenalidomide or bortezomib maintenance in patients with multiple myeloma not undergoing stem cell transplantation
|
Xu, Tianhong
|
|
|
102 |
Suppl 1 |
p. 1171-1184
|
artikel
|
| 156 |
Real-world treatments and thrombotic events in polycythemia vera patients in the USA
|
Verstovsek, Srdan
|
|
|
102 |
Suppl 1 |
p. 571-581
|
artikel
|
| 157 |
Recent national trends in outcomes and economic disparities among adult sickle cell disease-related admissions
|
Deenadayalan, Vaishali
|
|
|
102 |
Suppl 1 |
p. 2659-2669
|
artikel
|
| 158 |
Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry
|
Dingli, David
|
|
|
102 |
Suppl 1 |
p. 1637-1644
|
artikel
|
| 159 |
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma
|
Nowakowski, Grzegorz S.
|
|
|
102 |
Suppl 1 |
p. 1773-1787
|
artikel
|
| 160 |
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension
|
Mulas, Olga
|
|
|
102 |
Suppl 1 |
p. 2717-2723
|
artikel
|
| 161 |
Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis
|
Lübke, Johannes
|
|
|
102 |
Suppl 1 |
p. 2077-2085
|
artikel
|
| 162 |
Retrospective analysis of diagnosis and therapeutic strategies for patients with hepatosplenic T cell lymphoma
|
Jeon, Youngkyung
|
|
|
102 |
Suppl 1 |
p. 1867-1877
|
artikel
|
| 163 |
Risk–benefit ratio of percutaneous kyphoplasty and percutaneous vertebroplasty in patients with newly diagnosed multiple myeloma with vertebral fracture: a single-center retrospective study
|
Xiang, Qiu-Qing
|
|
|
102 |
Suppl 1 |
p. 1513-1522
|
artikel
|
| 164 |
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group
|
Saburi, Masuho
|
|
|
102 |
Suppl 1 |
p. 2507-2516
|
artikel
|
| 165 |
Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis
|
Zhang, Qiaolei
|
|
|
102 |
Suppl 1 |
p. 2301-2308
|
artikel
|
| 166 |
Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case–control study in the International PNH Registry
|
Höchsmann, Britta
|
|
|
102 |
Suppl 1 |
p. 2979-2988
|
artikel
|
| 167 |
Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database
|
Ammad Ud Din, Mohammad
|
|
|
102 |
Suppl 1 |
p. 889-895
|
artikel
|
| 168 |
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study
|
Berger, Tamar
|
|
|
102 |
Suppl 1 |
p. 2127-2136
|
artikel
|
| 169 |
Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
|
Liu, Jiapei
|
|
|
102 |
Suppl 1 |
p. 2865-2877
|
artikel
|
| 170 |
Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
|
Keklik, Muzaffer
|
|
|
102 |
Suppl 1 |
p. 1537-1547
|
artikel
|
| 171 |
Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial
|
Kurita, Naoki
|
|
|
102 |
Suppl 1 |
p. 2895-2902
|
artikel
|
| 172 |
Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study
|
Jiang, Shan
|
|
|
102 |
Suppl 1 |
p. 3205-3216
|
artikel
|
| 173 |
“Sandwich” protocol based on modified SMILE regimen for children with newly extranodal NK/T cell lymphoma, nasal type: a single-arm, single-center clinical study
|
Shen, Cheng-qi
|
|
|
102 |
Suppl 1 |
p. 3143-3152
|
artikel
|
| 174 |
Serum cytokine pattern in children with hemophagocytic lymphohistiocytosis
|
Ou, Wenxin
|
|
|
102 |
Suppl 1 |
p. 729-739
|
artikel
|
| 175 |
Sleep disordered breathing and its relation to stroke and pulmonary hypertension in children with sickle cell disease: a single-center cross-sectional study
|
Tantawy, Azza
|
|
|
102 |
Suppl 1 |
p. 271-281
|
artikel
|
| 176 |
Specific symptom burden in patients with chronic myeloproliferative neoplasms and chronic kidney disease
|
Holik, Hrvoje
|
|
|
102 |
Suppl 1 |
p. 1963-1965
|
artikel
|
| 177 |
Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement
|
Sayyadi, Mohammad
|
|
|
102 |
Suppl 1 |
p. 1307-1322
|
artikel
|
| 178 |
Superiority of polatuzumab vedotin over other novel agents in previously untreated ABC-type diffuse large B-cell lymphoma: a network meta-analysis of 20 RCTs
|
Sheng, Zhixin
|
|
|
102 |
Suppl 1 |
p. 1011-1017
|
artikel
|
| 179 |
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects
|
Geelen, Inge G.P.
|
|
|
102 |
Suppl 1 |
p. 1395-1408
|
artikel
|
| 180 |
Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study
|
Dufour, J.
|
|
|
102 |
Suppl 1 |
p. 1159-1169
|
artikel
|
| 181 |
Targeted next-generation sequencing identifies eighteen novel mutations expanding the molecular and clinical spectrum of PKLR gene disorders in the Indian population
|
Dongerdiye, Rashmi
|
|
|
102 |
Suppl 1 |
p. 1029-1036
|
artikel
|
| 182 |
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis
|
Fischer, Luca
|
|
|
102 |
Suppl 1 |
p. 2791-2801
|
artikel
|
| 183 |
The association between nutritional risk index and ICU outcomes across hematologic malignancy patients with acute respiratory failure
|
Kundu, Riddhi
|
|
|
102 |
Suppl 1 |
p. 439-445
|
artikel
|
| 184 |
The association of intestinal microbiota diversity and outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis
|
Wang, Shufen
|
|
|
102 |
Suppl 1 |
p. 3555-3566
|
artikel
|
| 185 |
The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease
|
Dai, Jia‑wen
|
|
|
102 |
Suppl 1 |
p. 3335-3343
|
artikel
|
| 186 |
The efficacy of first salvage therapy determines the outcomes of adult patients with type 1 primary refractory acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
|
Yu, Zhiyou
|
|
|
102 |
Suppl 1 |
p. 2627-2630
|
artikel
|
| 187 |
The experience of diagnosis and treatment for TAFRO syndrome
|
Wu, Xiaolong
|
|
|
102 |
Suppl 1 |
p. 3515-3520
|
artikel
|
| 188 |
The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survival
|
Hellou, Tamer
|
|
|
102 |
Suppl 1 |
p. 1037-1043
|
artikel
|
| 189 |
The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial
|
Gudmundstuen, Anne Marte
|
|
|
102 |
Suppl 1 |
p. 927-935
|
artikel
|
| 190 |
Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemia
|
Lin, Fan
|
|
|
102 |
Suppl 1 |
p. 2589-2598
|
artikel
|
| 191 |
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) — experience from Tata Memorial Hospital, India
|
Roy Moulik, Nirmalya
|
|
|
102 |
Suppl 1 |
p. 2835-2844
|
artikel
|
| 192 |
Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study
|
Zhang, Zhuxin
|
|
|
102 |
Suppl 1 |
p. 3039-3047
|
artikel
|
| 193 |
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry
|
Goveia, Lilian
|
|
|
102 |
Suppl 1 |
p. 2815-2822
|
artikel
|
| 194 |
Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis
|
Liu, Chunxiao
|
|
|
102 |
Suppl 1 |
p. 2387-2395
|
artikel
|
| 195 |
Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma
|
Yagi, Yu
|
|
|
102 |
Suppl 1 |
p. 1485-1500
|
artikel
|
| 196 |
Validation of venous thromboembolism predictive model in hematologic malignancies
|
López Sacerio, Agnerys
|
|
|
102 |
Suppl 1 |
p. 3613-3620
|
artikel
|
| 197 |
Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia
|
Li, Shanshan
|
|
|
102 |
Suppl 1 |
p. 787-794
|
artikel
|
| 198 |
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States
|
Zeidan, Amer M.
|
|
|
102 |
Suppl 1 |
p. 749-754
|
artikel
|
| 199 |
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study
|
Shen, Yingying
|
|
|
102 |
Suppl 1 |
p. 503-517
|
artikel
|
Tijdschrift beschrijving